Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson’s disease models are mediated by GPR109A-dependent mechanisms
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson’s disease models are mediated by GPR109A-dependent mechanisms
Authors
Keywords
BHBA, GPR109A, Parkinson’s disease, neuroinflammation, LPS, NF-κB
Journal
Journal of Neuroinflammation
Volume 12, Issue 1, Pages 9
Publisher
Springer Nature
Online
2015-01-16
DOI
10.1186/s12974-014-0230-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
- (2014) Nagendra Singh et al. IMMUNITY
- Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate’s protective effect in EAE
- (2014) Hui Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- BHBA Suppresses LPS-Induced Inflammation in BV-2 Cells by Inhibiting NF-κB Activation
- (2014) Shou-Peng Fu et al. MEDIATORS OF INFLAMMATION
- Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease
- (2014) Stefka Gyoneva et al. NEUROBIOLOGY OF DISEASE
- The role of inflammation in sporadic and familial Parkinson’s disease
- (2013) Michela Deleidi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The role of HCA2 (GPR109A) in regulating macrophage function
- (2013) Kambiz Zandi-Nejad et al. FASEB JOURNAL
- Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models
- (2013) Wenjiao Tai et al. NEUROPHARMACOLOGY
- Innate Inflammation in Parkinson's Disease
- (2013) V. H. Perry Cold Spring Harbor Perspectives in Medicine
- Anti-Inflammatory Effects of Nicotinic Acid in Human Monocytes Are Mediated by GPR109A Dependent Mechanisms
- (2012) Janet E. Digby et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Further characterisation of the LPS model of Parkinson’s disease: A comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat
- (2012) Deirdre B. Hoban et al. BRAIN BEHAVIOR AND IMMUNITY
- Neuroprotection by Silencing iNOS Expression in a 6-OHDA Model of Parkinson’s Disease
- (2012) Min Li et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Glycogen synthase kinase-3β inactivation inhibits tumor necrosis factor-α production in microglia by modulating nuclear factor κB and MLK3/JNK signaling cascades
- (2011) Mei-Jen Wang et al. Journal of Neuroinflammation
- D-β-Hydroxybutyrate Is Protective in Mouse Models of Huntington's Disease
- (2011) Soyeon Lim et al. PLoS One
- Gastrodin Inhibits Expression of Inducible NO Synthase, Cyclooxygenase-2 and Proinflammatory Cytokines in Cultured LPS-Stimulated Microglia via MAPK Pathways
- (2011) Ji-Nan Dai et al. PLoS One
- Expression of interleukin 6 in brain and colon of rats with TNBS-induced colitis
- (2010) Kai Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Peripheral cytokines profile in Parkinson’s disease
- (2008) M. Reale et al. BRAIN BEHAVIOR AND IMMUNITY
- Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide
- (2008) María del Carmen Hernández-Romero et al. JOURNAL OF NEUROCHEMISTRY
- Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease
- (2008) James B Koprich et al. Journal of Neuroinflammation
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started